Literature DB >> 33925860

Drug Delivery Approaches for Managing Overactive Bladder (OAB): A Systematic Review.

Zara Khizer1, Amina Sadia2, Raman Sharma3, Samia Farhaj1, Jorabar Singh Nirwan1, Pratibha G Kakadia4, Talib Hussain5, Abid Mehmood Yousaf5, Yasser Shahzad5, Barbara R Conway1, Muhammad Usman Ghori1.   

Abstract

Overactive bladder syndrome (OAB) is characterised by urgency symptoms, with or without urgency incontinence, usually with frequency and nocturia and severely affects the quality of life. This systematic review evaluates the various drug delivery strategies used in practice to manage OAB. Advanced drug delivery strategies alongside traditional strategies were comprehensively analysed and comparatively evaluated. The present review was conducted according to the preferred reporting items for systematic reviews and meta-analyses guidelines. A total of 24 studies reporting the development of novel formulations for the treatment of OAB were considered eligible and were further categorised according to the route of drug administration. The review found that various drug delivery routes (transdermal, intravesicular, oral, vaginal and intramuscular) are used for the administration of drugs for managing OAB, however, the outcomes illustrated the marked potential of transdermal drug delivery route. The findings of the current review are expected to be helpful for pharmaceutical scientists to better comprehend the existing literature and challenges and is anticipated to provide a basis for designing and fabricating novel drug delivery systems to manage OAB.

Entities:  

Keywords:  drug delivery; oral drug delivery; overactive bladder; pharmacotherapy; systematic review; transdermal drug delivery

Year:  2021        PMID: 33925860     DOI: 10.3390/ph14050409

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN: 1424-8247


  75 in total

1.  Prevalence of overactive bladder and associated risk factors in 1359 patients with type 2 diabetes.

Authors:  Rue-Tsuan Liu; Min-Shen Chung; Wei-Chia Lee; Sueh-Wen Chang; Siang-Ting Huang; Kuender D Yang; Michael B Chancellor; Yao-Chi Chuang
Journal:  Urology       Date:  2011-09-28       Impact factor: 2.649

Review 2.  Developments in pharmacological therapy for the overactive bladder.

Authors:  Christopher R Chapple; E Ann Gormley
Journal:  BJU Int       Date:  2006-09       Impact factor: 5.588

Review 3.  Skin permeabilization for transdermal drug delivery: recent advances and future prospects.

Authors:  Carl M Schoellhammer; Daniel Blankschtein; Robert Langer
Journal:  Expert Opin Drug Deliv       Date:  2014-01-07       Impact factor: 6.648

Review 4.  A myogenic basis for the overactive bladder.

Authors:  A F Brading
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

Review 5.  Managing overactive bladder.

Authors:  D Robinson; L Cardozo
Journal:  Climacteric       Date:  2019-06       Impact factor: 3.005

6.  Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence.

Authors:  Roger R Dmochowski; Peter K Sand; Norman R Zinner; Marc C Gittelman; G Willy Davila; Steven W Sanders
Journal:  Urology       Date:  2003-08       Impact factor: 2.649

Review 7.  Why consider vaginal drug administration?

Authors:  Nancy J Alexander; Edward Baker; Marc Kaptein; Ulrich Karck; Leslie Miller; Edio Zampaglione
Journal:  Fertil Steril       Date:  2004-07       Impact factor: 7.329

8.  Bother related to bladder control and health care seeking behavior in adults in the United States.

Authors:  Joshua S Benner; Russell Becker; Kristina Fanning; Zhanna Jumadilova; Tamara Bavendam; Linda Brubaker
Journal:  J Urol       Date:  2009-04-16       Impact factor: 7.450

9.  Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder.

Authors:  M Haupt; M Thommes; A Heidenreich; J Breitkreutz
Journal:  J Control Release       Date:  2013-06-01       Impact factor: 9.776

10.  Development of long-acting bioadhesive vaginal gels of oxybutynin: formulation, in vitro and in vivo evaluations.

Authors:  Fatmanur Tuğcu-Demiröz; Füsun Acartürk; Deniz Erdoğan
Journal:  Int J Pharm       Date:  2013-09-13       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.